---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-038962"
form_type: "8-K"
ticker: "SKIN"
cik: "0001818093"
company_name: "SkinHealth Systems Inc."
filed_at: "2024-08-30T23:59:59+00:00"
generated_at: "2026-05-31T06:50:17.555888+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Director Julius Few resigns from Beauty Health board effective immediately

## Summary
- Dr. Julius Few resigned as director on August 26, 2024; also left Nominating and Corporate Governance Committee.
- Resignation was not due to any dispute with company, management, or board.
- Michael Monahan, CFO, signed the Form 8-K on August 30, 2024.

## SEC filing metadata
- accession: 0001628280-24-038962
- form_type: 8-K
- ticker: SKIN
- cik: 0001818093
- company_name: SkinHealth Systems Inc.
- filed_at: 2024-08-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818093/000162828024038962/0001628280-24-038962-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818093/000162828024038962/skin-20240826.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-038962
- JSON: https://secwatch.observer/filing/0001628280-24-038962.json
- Plain text: https://secwatch.observer/filing/0001628280-24-038962.txt

## Key facts
- Executive change
  Julius Few resigned as director at SkinHealth Systems Inc..
  - Action: resigned
  - Role: director
  source text: On August 26, 2024, Dr. Julius Few notified the board of directors (the "Board") of The Beauty Health Company (the "Company") of his decision to resign as a director of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000162828024038962/0001628280-24-038962-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.